Theravance Biopharma Inc (TBPH) valuation · $861.5M cap
Theravance Biopharma Inc (TBPH) $861.5M cap.
| Metric | Value |
|---|---|
| Market cap | $861.5M |
| Revenue | $20.7M |
| P/S | 41.6 |
| P/B | 3.0 |
TBPH valuation FAQ
What is TBPH's market cap?
Theravance Biopharma Inc (TBPH) market cap is $861.5M on the latest cached fundamentals snapshot.
What is TBPH's latest revenue?
Latest cached Theravance Biopharma Inc (TBPH) revenue was $20.7M. Statements: https://lician.com/financials/tbph
What is TBPH's price-to-sales ratio?
Theravance Biopharma Inc (TBPH) price-to-sales (P/S) is 41.6, cached market cap $861.5M divided by revenue $20.7M.
What is TBPH's price-to-book ratio?
Theravance Biopharma Inc (TBPH) price-to-book (P/B) is 3.0 on the latest cached fundamentals snapshot.
How many TBPH valuation scalars are listed on this page?
This page lists 4 cached valuation scalars for Theravance Biopharma Inc (TBPH): Market cap, Revenue, P/S, and P/B.
Where is TBPH valuation listed?
Cached valuation multiples for Theravance Biopharma Inc (TBPH) are listed at https://lician.com/valuation/tbph.
Not investment advice. Cached rows, not a live tape.